These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
239 related articles for article (PubMed ID: 18336060)
1. Pregnancy outcome after in utero exposure to valproate : evidence of dose relationship in teratogenic effect. Diav-Citrin O; Shechtman S; Bar-Oz B; Cantrell D; Arnon J; Ornoy A CNS Drugs; 2008; 22(4):325-34. PubMed ID: 18336060 [TBL] [Abstract][Full Text] [Related]
2. First-trimester itraconazole exposure and pregnancy outcome: a prospective cohort study of women contacting teratology information services in Italy. De Santis M; Di Gianantonio E; Cesari E; Ambrosini G; Straface G; Clementi M Drug Saf; 2009; 32(3):239-44. PubMed ID: 19338381 [TBL] [Abstract][Full Text] [Related]
3. Pregnancy outcome following in utero exposure to lithium: a prospective, comparative, observational study. Diav-Citrin O; Shechtman S; Tahover E; Finkel-Pekarsky V; Arnon J; Kennedy D; Erebara A; Einarson A; Ornoy A Am J Psychiatry; 2014 Jul; 171(7):785-94. PubMed ID: 24781368 [TBL] [Abstract][Full Text] [Related]
4. Valproic acid in pregnancy: how much are we endangering the embryo and fetus? Ornoy A Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988 [TBL] [Abstract][Full Text] [Related]
5. Cross-sectional evaluation of prescription of valproate and other antiepileptic drugs to pregnant women. Aykan DA; Ergün Y Acta Neurol Belg; 2021 Apr; 121(2):503-508. PubMed ID: 31659713 [TBL] [Abstract][Full Text] [Related]
6. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations. Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509 [TBL] [Abstract][Full Text] [Related]
7. Dose dependence of fetal malformations associated with valproate. Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758 [TBL] [Abstract][Full Text] [Related]
8. Valproate and the risk for congenital malformations: Is formulation and dosage regime important? Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656 [TBL] [Abstract][Full Text] [Related]
9. Prenatal exposure to teratogenic medications in the era of Risk Evaluation and Mitigation Strategies. Sarayani A; Albogami Y; Thai TN; Smolinski NE; Patel P; Wang Y; Nduaguba S; Rasmussen SA; Winterstein AG Am J Obstet Gynecol; 2022 Aug; 227(2):263.e1-263.e38. PubMed ID: 35032444 [TBL] [Abstract][Full Text] [Related]
10. Common teratogenic medication exposures-a population-based study of pregnancies in the United States. Wang Y; Smolinski NE; Thai TN; Sarayani A; Ewig C; Rasmussen SA; Winterstein AG Am J Obstet Gynecol MFM; 2024 Jan; 6(1):101245. PubMed ID: 38061552 [TBL] [Abstract][Full Text] [Related]
11. Valproic acid monotherapy in pregnancy and major congenital malformations. Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT; N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369 [TBL] [Abstract][Full Text] [Related]
12. The teratogenic risk of antiepileptic drug polytherapy. Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810 [TBL] [Abstract][Full Text] [Related]
13. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers. Campbell E; Kennedy F; Russell A; Smithson WH; Parsons L; Morrison PJ; Liggan B; Irwin B; Delanty N; Hunt SJ; Craig J; Morrow J J Neurol Neurosurg Psychiatry; 2014 Sep; 85(9):1029-34. PubMed ID: 24444855 [TBL] [Abstract][Full Text] [Related]
14. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F; Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205 [TBL] [Abstract][Full Text] [Related]
15. Pregnancy outcome after gestational exposure to loratadine or antihistamines: a prospective controlled cohort study. Diav-Citrin O; Shechtman S; Aharonovich A; Moerman L; Arnon J; Wajnberg R; Ornoy A J Allergy Clin Immunol; 2003 Jun; 111(6):1239-43. PubMed ID: 12789223 [TBL] [Abstract][Full Text] [Related]
16. Is it safe to use lamotrigine during pregnancy? A prospective comparative observational study. Diav-Citrin O; Shechtman S; Zvi N; Finkel-Pekarsky V; Ornoy A Birth Defects Res; 2017 Sep; 109(15):1196-1203. PubMed ID: 28657171 [TBL] [Abstract][Full Text] [Related]
17. Valproate in Pregnancy: Recent Research and Regulatory Responses. Andrade C J Clin Psychiatry; 2018; 79(3):. PubMed ID: 29873961 [TBL] [Abstract][Full Text] [Related]
18. In utero antiepileptic drug exposure: fetal death and malformations. Meador KJ; Baker GA; Finnell RH; Kalayjian LA; Liporace JD; Loring DW; Mawer G; Pennell PB; Smith JC; Wolff MC; Neurology; 2006 Aug; 67(3):407-12. PubMed ID: 16894099 [TBL] [Abstract][Full Text] [Related]
19. Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine. Deshmukh U; Adams J; Macklin EA; Dhillon R; McCarthy KD; Dworetzky B; Klein A; Holmes LB Neurotoxicol Teratol; 2016; 54():5-14. PubMed ID: 26791321 [TBL] [Abstract][Full Text] [Related]
20. Malformation risk of antiepileptic drug exposure during pregnancy in women with epilepsy: Results from a pregnancy registry in South India. Thomas SV; Jose M; Divakaran S; Sankara Sarma P Epilepsia; 2017 Feb; 58(2):274-281. PubMed ID: 28084641 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]